<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">amedj</journal-id><journal-title-group><journal-title xml:lang="ru">Амурский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Amur Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2311-5068</issn><issn pub-type="epub">3033-831X</issn><publisher><publisher-name>Амурская государственная медицинская академия</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24412/2311-5068-2023-11-1-5</article-id><article-id custom-type="elpub" pub-id-type="custom">amedj-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LITERATURE REVIEW</subject></subj-group></article-categories><title-group><article-title>Постковидный синдром – что мы знаем о нем?</article-title><trans-title-group xml:lang="en"><trans-title>What do we know about post-COVID syndrome?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бакина</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bakina</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Анастасия Алексеевна Бакина - ассистент кафедры факультетской и поликлинической терапии</p><p>Благовещенск</p></bio><bio xml:lang="en"><p>Anastasiya A. Bakina</p><p>Blagoveshchensk</p></bio><email xlink:type="simple">anastasia_darchi@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Павленко</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Pavlenko</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Валентина Ивановна Павленко - д-р. мед. наук, доцент, профессор кафедры факультетской и поликлинической терапии</p><p>Благовещенск</p></bio><bio xml:lang="en"><p>Valentina I. Pavlenko</p><p>Blagoveshchensk</p></bio><email xlink:type="simple">agmapedfac@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щегорцова</surname><given-names>Ю. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Shchegortsova</surname><given-names>Yu. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Юлия Юрьевна Щегорцова - ассистент кафедры факультетской и поликлинической терапии</p><p>Благовещенск</p></bio><bio xml:lang="en"><p>Yuliya Yu. Shchegortsova</p><p>Blagoveshchensk</p></bio><email xlink:type="simple">shchegortsova92@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО Амурская ГМА Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Amur State Medical Academy of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>15</day><month>12</month><year>2025</year></pub-date><volume>11</volume><issue>1</issue><fpage>5</fpage><lpage>15</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бакина А.А., Павленко В.И., Щегорцова Ю.Ю., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Бакина А.А., Павленко В.И., Щегорцова Ю.Ю.</copyright-holder><copyright-holder xml:lang="en">Bakina A.A., Pavlenko V.I., Shchegortsova Y.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.amedj.ru/jour/article/view/9">https://www.amedj.ru/jour/article/view/9</self-uri><abstract><p>Актуальным направлением исследований является оценка последствий действия коронавируса на организм человека в рамках постковидного синдрома (ПКС). Цель литературного обзора: изучить и обобщить данные об особенностях проявления и течения ПКС по данным современных исследователей, отраженным в литературе преимущественно за последние 3 года. Проявления ПКС крайне вариабельны, имеют различную продолжительность и выраженность. Как правило, пациентов, страдающих от проявлений ПКС, беспокоят состояние стойкой усталости, перепады настроения, сохраняющаяся респираторная симптоматика, нарушения в когнитивной и психоэмоциональной сфере. Частыми психоневрологическими проявлениями ПКС могут быть нарушения речи, головная боль, дисгевзия, гипо- или аносмия. Тяжелое течение ПКС может провоцировать развитие острого нарушения мозгового кровообращения, синдрома Гийена-Барре, энцефалита или энцефалопатии. Симптоматика ПКС может варьировать от сохраняющихся длительное время кашля, одышки, постуральной ортостатической тахикардии до таких тяжелых состояний, как почечная недостаточность, миокардит и легочный фиброз. Стойкость проявлений ПКС может быть различна. В подавляющем большинстве случаев ПКС купируется полностью, в то время как у некоторых пациентов он имеет стойкие проявления. Ощущение сердцебиения и кардиалгия исчезали в среднем спустя 8 месяцев после перенесенного COVID-19, а такие жалобы, как выраженная утомляемость и одышка сохранялись до 1 года после перенесенного заболевания. Обнаружено, что число хронических соматических патологий ассоциировано с частотой возникновения повышенной утомляемости и одышки после перенесенного COVID-19. Таким образом, в ходе изучения данных исследователей, было установлено, что проявления ПКС имеют мультисистемный характер и длительную персистенцию. Наиболее часто после перенесенного COVID-19 возникает чувство усталости, снижение толерантности к физическим нагрузкам, нарушения когнитивной и психоэмоциональной сферы.</p></abstract><trans-abstract xml:lang="en"><p>The study of post-COVID syndrome (PCS) is relevant. The aim of the review is to study and summarize data on the features of PCS from the literature over the past 3 years. Manifestations of PCS have many variants, different duration and severity. Patients with PCS suffer from fatigue, mood swings and persistent respiratory symptoms, cognitive and psycho-emotional disturbances. Frequent neuropsychiatric manifestations of PCS are speech disorders, headache, dysgeusia, hypo- or anosmia. Severe PCS can provoke the development of acute cerebrovascular accident, Guillain-Barré syndrome, encephalitis or encephalopathy. The researchers found that the symptoms of PCS can range from persistent cough, dyspnea and postural orthostatic tachycardia to renal failure, myocarditis, and pulmonary fibrosis. The persistence of manifestations of PCS can be different. Often, PCS is completely stopped, but in some patients it has persistent manifestations. The researchers found that tachycardia and cardialgia disappeared in 8 months after suffering COVID-19. Fatigue and dyspnea persisted up to 1 year after experiencing COVID-19. The number of chronic somatic pathologies is associated with the incidence of increased fatigue and dyspnea after suffering from COVID-19. Thus, it was found that the manifestations of PCS have a multisystem character and long-term persistence. Most often there are feelings of fatigue, a decrease in tolerance to physical activity, cognitive and psycho-emotional disorders after suffering from COVID-19.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>коронавирусная инфекция</kwd><kwd>COVID-19</kwd><kwd>постковидный синдром</kwd><kwd>утомляемость</kwd><kwd>одышка</kwd></kwd-group><kwd-group xml:lang="en"><kwd>coronavirus infection</kwd><kwd>COVID-19</kwd><kwd>post-COVID syndrome</kwd><kwd>tiredness</kwd><kwd>dyspnea</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бакина А. А., Павленко В. И., Хрипунова О. А. Особенности рентгенологической картины COVID-19 – пневмонии // XXXII Национальный конгресс по болезням органов дыхания : сборник трудов; под редакцией акад. А.Г. Чучалина. Москва : ДизайнПресс, 2022. С. 77.</mixed-citation><mixed-citation xml:lang="en">Bakina AA, Pavlenko VI, Khripunova ОА. Osobennosti rentgenologicheskoi kartiny COVID-19 – pnevmonii [Features of X-ray for pneumonia at Covid-19]. XXXII Natsional’nyi kongress po boleznyam organov dykhaniya : sbornik trudov [XXXII National Congress on respiratory diseases. Collection of works of Congress. Chucalin AG (ed.)]. Moscow: Design press; 2022. P. 77. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Кулик Е. Г., Павленко В. И., Нарышкина С. В. Показатели качества жизни у больных ХОБЛ, перенесших новую коронавирусную инфекцию // XXXII Национальный конгресс по болезням органов дыхания : сборник трудов; под редакцией акад. А.Г. Чучалина. Москва : ДизайнПресс, 2022. С. 130.</mixed-citation><mixed-citation xml:lang="en">Kulik EG, Pavlenko VI, Naryshkina SV. Pokazateli kachestva zhizni u bol’nykh KhOBL, perenesshikh novuyu koronavirusnuyu infektsiyu [Indicators of the quality of life in patients with COPD and COVID-19]. XXXII Natsional’nyi kongress po boleznyam organov dykhaniya : sbornik trudov [XXXII National Congress on respiratory diseases. Collection of works of Congress. Chucalin AG (ed.)]. Moscow: Design press; 2022. P. 130. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Кулик Е. Г., Павленко В. И., Нарышкина С. В. Сравнительный анализ клинико-лабораторных показателей у больных ХОБЛ в зависимости от наличия обострения или новой коронавирусной инфекции // Бюллетень физиологии и патологии дыхания. 2022. № 85. С.26-31. https://doi.org/10.36604/1998-5029-2022-85-26-31.</mixed-citation><mixed-citation xml:lang="en">Kulik E.G., Pavlenko V.I., Naryshkina S.V. Sravnitel’nyi analiz kliniko-laboratornykh pokazatelei u bol’nykh KhOBL v zavisimosti ot nalichiya obostreniya ili novoi koronavirusnoi infektsii [Comparative analysis of clinical and laboratory features in patients with chronic obstructive pulmonary disease depending on the presence of an exacerbation or a novel coronavirus infection]. Byulleten’ fiziologii i patologii dykhaniya . – Bulletin Physiology and Pathology of Respiration. 2022;85:26–31 (In Russ.). https://doi.org/10.36604/19985029-2022-85-26-31.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Павленко В.И., Кулик Е.Г., Нарышкина С.В. Хроническая обструктивная болезнь легких как коморбидное состояние при COVID-19 // Амурский медицинский журнал. 2021. № 1(31). С.11-17. https://doi.org/10.24412/2311-5068-2021-1-11-17. EDN: NHRQCQ.</mixed-citation><mixed-citation xml:lang="en">Pavlenko V.I., Kulik E.G., Naryshkina S.V. Khronicheskaya obstruktivnaya bolezn’ legkikh kak komorbidnoe sostoyanie pri COVID-19 [Chronic obstructive pulmonary disease as a comorbid state in Covid-19]. Amurskii meditsinskii zhurnal. – Amur Medical Journal. 2021;1(31):11–17. (In Russ.). https://doi.org/10.24412/2311-5068-2021-1-11-17.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. Post-COVID syndrome in individuals admitted to hospital with covid-19: retrospective cohort study // BMJ. 2021. № 372. Р. n693. https://doi.org/10.1136/bmj.n693.</mixed-citation><mixed-citation xml:lang="en">Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, Banerjee A. Post-COVID syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372:n693. https://doi.org/10.1136/bmj.n693.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., Lin K., Mansur R.B., Ho R.C., Rosenblat J.D., Miskowiak K.W., Vinberg M., Maletic V., McIntyre R.S. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and metaanalysis / // Brain Behav Immun. 2022. № 101. P. 93-135. https://doi.org/10.1016/j.bbi.2021.12.020.</mixed-citation><mixed-citation xml:lang="en">Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022;101:93-135. https:// doi.org/10.1016/j.bbi.2021.12.020.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chan J.F., Yuan S., Kok K.H., To K.K., Chu H., Yang J., и др. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster // Lancet. 2020. Vol. 395. P. 514-523. https://doi.org/10.1016/S0140-6736(20)30154-9.</mixed-citation><mixed-citation xml:lang="en">Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514-523. https://doi.org/10.1016/S0140-6736(20)30154-9.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Changeux J.P., Amoura Z., Rey F.A., Miyara M. A nicotinic hypothesis for COVID-19 with preventive and therapeutic implications // C R Biol. 2020. № 343(1). Р.1–7. https://doi.org/10.5802/crbiol.8. PMID: 32720486.</mixed-citation><mixed-citation xml:lang="en">Changeux JP, Amoura Z, Rey FA, Miyara M. A nicotinic hypothesis for COVID-19 with preventive and therapeutic implications. C R Biol. 2020;343(1):1–7. https://doi.org/10.5802/crbiol.8. PMID: 32720486.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Chudzik M., Babicki M., Kapusta J., Kałuzińska-Kołat Ż., Kołat D., Jankowski P., Mastalerz-Migas A. Long-COVID clinical features and risk factors: a retrospective analysis of patients from the STOP-COVID registry of the PoLoCOV study // Viruses. 2022. № 14(8). Р.1755. https://doi.org/10.3390/v14081755.</mixed-citation><mixed-citation xml:lang="en">Chudzik M, Babicki M, Kapusta J, Kałuzińska-Kołat Ż, Kołat D, Jankowski P., Mastalerz-Migas A. Long-COVID clinical features and risk factors: a retrospective analysis of patients from the STOP-COVID registry of the PoLoCOV study. Viruses. 2022;14(8):1755. https://doi.org/10.3390/v14081755.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Chung T.H., Azar A. Autonomic nerve involvement in post-acute sequelae of SARS-CoV-2 syndrome (PASC) // J Clin Med. 2022. № 12(1). Р. 73. https://doi.org/10.3390/jcm12010073.</mixed-citation><mixed-citation xml:lang="en">Chung TH, Azar A. Autonomic nerve involvement in post-acute sequelae of SARS-CoV-2 syndrome (PASC). J Clin Med. 2022;12(1):73. https://doi.org/10.3390/jcm12010073.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Coronavirus disease (COVID-19) – World Health Organization. Accessed June 27, 2021. https:// www.who.int/emergencies/diseases/novel-coronavirus-2019.</mixed-citation><mixed-citation xml:lang="en">Coronavirus disease (COVID-19) – World Health Organization. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. [Accessed: June 27, 2021]</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re’em Y., и др. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact // E Clinical Medicine. 2021. № 38. P. 101019. https://doi.org/10.1016/j.eclinm.2021.101019.</mixed-citation><mixed-citation xml:lang="en">Davis HE, Assaf G.S, McCorkell L, Wei H, Low RJ, Re’em Y., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. E Clinical Medicine. 2021;38:101019. https:// doi.org/10.1016/j.eclinm.2021.101019.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Feikin D.R., Higdon M.M., Abu-Raddad L.J., Andrews N., Araos R., Goldberg Y., Groome M.J., Huppert A., O’Brien K.L., Smith P.G., Wilder-Smith A., Zeger S., Deloria Knoll M., Patel M.K. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and metaregression // Lancet. 2022. Vol. 399. P. 924-944. https://doi.org/10.1016/S0140-6736(22)00152-0.</mixed-citation><mixed-citation xml:lang="en">Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y., et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022;399:924-44. https://doi.org/10.1016/S0140-6736(22)00152-0.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Fernández-de-Las-Peñas C., Gómez-Mayordomo V., Cuadrado M.L., Palacios-Ceña D., Florencio L.L., Guerrero A.L., García-Azorín D., Hernández-Barrera V., Arendt-Nielsen L. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study // Cephalalgia. 2021. № 41(13). Р.1332-1341. https://doi.org/10.1177/03331024211020404.</mixed-citation><mixed-citation xml:lang="en">Fernández-de-Las-Peñas C, Gómez-Mayordomo V, Cuadrado ML, Palacios-Ceña D, Florencio LL, Guerrero AL., et al. The presence of headache at onset in SARS-CoV-2 infection is associated with longterm post-COVID headache and fatigue: A case-control study. Cephalalgia. 2021:41(13):1332-41. https://doi.org/10.1177/03331024211020404.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Fernández-de-Las-Peñas C., Guijarro C., Torres-Macho J., Velasco-Arribas M., Plaza-Canteli S., Hernández-Barrera V., Arias-Navalón J.A. Diabetes and the risk of long-term post-COVID symptoms // Diabetes. 2021. № 70(12). Р.2917-2921. https://doi.org/10.2337/db21-0329.</mixed-citation><mixed-citation xml:lang="en">Fernández-de-Las-Peñas C, Guijarro C, Torres-Macho J, Velasco-Arribas M, Plaza-Canteli S, Hernández-Barrera V., et al. Diabetes and the risk of long-term post-COVID symptoms. Diabetes. 2021; 70(12):2917-21. https://doi.org/10.2337/db21-0329.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Fernández-de-Las-Peñas C., Rodríguez-Jiménez J., Cancela-Cilleruelo I., Guerrero-Peral A., Martín-Guerrero J.D., García-Azorín D., Cornejo-Mazzuchelli A., Hernández-Barrera V., Pellicer-Valero O.J. Post-COVID-19 symptoms 2 years after SARS-CoV-2 infection among hospitalized vs nonhospitalized patients // JAMA Netw Open. 2022. № 5(11). Р.e2242106. https://doi.org/10.1001/jamanetworkopen.2022.42106.</mixed-citation><mixed-citation xml:lang="en">Fernández-de-Las-Peñas C., Rodríguez-Jiménez J., Cancela-Cilleruelo I., Guerrero-Peral A., Martín-Guerrero J.D., García-Azorín D., et al. Post-COVID-19 symptoms 2 years after SARS-CoV-2 infection among hospitalized vs nonhospitalized patients. JAMA Netw Open. 2022;5(11):e2242106. https://doi.org/10.1001/jamanetworkopen.2022.42106.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Fernández-de-Las-Peñas C., Ryan-Murua P., Rodríguez-Jiménez J., Palacios-Ceña M., Arendt-Nielsen L., Torres-Macho J. Serological biomarkers at hospital admission are not related to long-term post-COVID fatigue and dyspnea in COVID-19 survivors // Respiration. 2022. № 101(7). Р. 658–665. https://doi.org/10.1159/000524042.</mixed-citation><mixed-citation xml:lang="en">Fernández-de-Las-Peñas C, Ryan-Murua P, Rodríguez-Jiménez J, Palacios-Ceña M, Arendt-Nielsen L, Torres-Macho J. Serological biomarkers at hospital admission are not related to long-term post-COVID fatigue and dyspnea in COVID-19 survivors. Respiration. 2022;101(7):658-665. https://doi.org/10.1159/000524042.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Goërtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, Houben-Wilke S, Burtin C, Posthuma R, Franssen FME, van Loon N, Hajian B, Spies Y, Vijlbrief H, van ‘t Hul AJ, Janssen DJA, Spruit MA. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020 Oct 26;6(4):00542-2020. https://doi.org/10.1183/23120541.00542-2020. PMID: 33257910; PMCID: PMC7491255.</mixed-citation><mixed-citation xml:lang="en">Goërtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, Houben-Wilke S, Burtin C, Posthuma R, Franssen FME, van Loon N, Hajian B, Spies Y, Vijlbrief H, van ‘t Hul AJ, Janssen DJA, Spruit MA. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020 Oct 26;6(4):00542-2020. https://doi.org/10.1183/23120541.00542-2020. PMID: 33257910; PMCID: PMC7491255.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Guntur V.P., Nemkov T., de Boer E., Mohning M.P., Baraghoshi D., Cendali F.I., San-Millán I., Petrache I., D’Alessandro A. Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC) // Metabolites. 2022. № 12(11). Р.1026. https://doi. org/10.3390/metabo12111026.</mixed-citation><mixed-citation xml:lang="en">Guntur VP, Nemkov T, de Boer E, Mohning MP, Baraghoshi D, Cendali FI., et al. Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC). Metabolites. 2022;12(11):1026. https://doi.org/10.3390/metabo12111026.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Holshue M.L., DeBolt C., Lindquist S., Lofy K.H., Wiesman J., Bruce H., Spitters C., Ericson K., Wilkerson S., Tural A., Diaz G., Cohn A., Fox L., Patel A., Gerber S.I., Kim L., Tong S., Lu X., Lindstrom S., Pallansch M.A., Weldon W.C., Biggs H.M., Uyeki T.M., Pillai S.K. Washington State 2019-nCoV Case Investigation Team. First Case of 2019 Novel Coronavirus in the United States // N Engl J Med. 2020. Vol. 382. № 10. Р. 929-936. https://doi.org/10.1056/NEJMoa2001191.</mixed-citation><mixed-citation xml:lang="en">Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H., et al. Washington State 2019-nCoV Case Investigation Team. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020;382;10:929-936. https://doi.org/10.1056/NEJMoa2001191.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China // Lancet. 2020. Vol. 395. P. 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5.</mixed-citation><mixed-citation xml:lang="en">Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. https://doi.org/10.1016/S0140-6736(20)30183-5.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kamal M., Abo Omirah M., Hussein A., Saeed H. Assessment and characterisation of post-COVID-19 manifestations // Int J Clin Pract. 2021. № 75. Р. e13746. https://doi.org/10.1111/ijcp.13746.</mixed-citation><mixed-citation xml:lang="en">Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021;75:e13746. https://doi.org/10.1111/ijcp.13746.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Lee J.H., Yim J.J., Park J. Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis // Respir Res. 2022. № 23(1). Р. 233. https://doi.org/10.1186/s12931-022-02163-x.</mixed-citation><mixed-citation xml:lang="en">Lee JH, Yim JJ, Park J. Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis. Respir Res. 2022;23(1):233. Https://doi.org/10.1186/s12931-022-02163-x.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Liang L., Yang B., Jiang N., Fu W., He X., Zhou Y., Ma W.L., Wang X. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge // J Korean Med Sci. 2020. № 35(47). Р. e418. https:// doi.org/10.3346/jkms.2020.35.e418.</mixed-citation><mixed-citation xml:lang="en">Liang L, Yang B, Jiang N, Fu W, He X, Zhou Y., et al. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge. J Korean Med Sci. 2020;35(47):e418. https://doi.org/10.3346/jkms.2020.35.e418.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Loosen S.H., Jensen B.O., Tanislav C., Luedde T., Roderburg C., Kostev K. Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients // Infection. 2022. № 50(5). Р.1165-70. https://doi.org/10.1007/s15010-022-01784-0.</mixed-citation><mixed-citation xml:lang="en">Loosen SH, Jensen BO, Tanislav C, Luedde T, Roderburg C, Kostev K. Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients. Infection. 2022;50(5):1165-1170. https://doi.org/10.1007/s15010-022-01784-0.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Mizrahi B., Sudry T., Flaks-Manov N., Yehezkelli Y., Kalkstein N., Akiva P., Ekka-Zohar A., Ben David S.S., Lerner U., Bivas-Benita M., Greenfeld S. Long COVID outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study // BMJ. 2023. № 380. Р.e072529. https://doi.org/10.1136/bmj-2022-072529.</mixed-citation><mixed-citation xml:lang="en">Mizrahi B, Sudry T, Flaks-Manov N, Yehezkelli Y, Kalkstein N, Akiva P., et al. Long COVID outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ. 2023;380:e072529. https://doi.org/10.1136/bmj-2022-072529.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., Ahluwalia N., Bikdeli B., Dietz D., Der-Nigoghossian C., Liyanage-Don N., Rosner G.F., Bernstein E.J., Mohan S., Beckley A.A., Seres D.S., Choueiri T.K., Uriel N., Ausiello J.C., Accili D., Freedberg D.E., Baldwin M., Schwartz A., Brodie D., Garcia C.K., Elkind M.S.V., Connors J.M., Bilezikian J.P., Landry D.W., Wan E.Y. Post-acute COVID-19 syndrome // Nat Med. 2021. Vol. 27. № 4. P. 601-615. https://doi.org/10.1038/s41591-021-01283-z.</mixed-citation><mixed-citation xml:lang="en">Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27;4:601-615. https://doi.org/10.1038/s41591-021-01283-z.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Nateghi S., Hesari E., Mansouri F., Akrami M., Pourian M., Khosravani A., Taghizadeh F., Akbarpour S., Faraji N. Evaluation of blood biochemistry and cardiopulmonary status of hospitalized COVID-19 patients in 3 months post discharged follow up survey // Clin Med Insights Circ Respir Pulm Med. 2022. № 16. Р.11795484221119332. https://doi.org/10.1177/11795484221119332.</mixed-citation><mixed-citation xml:lang="en">Nateghi S, Hesari E, Mansouri F, Akrami M, Pourian M, Khosravani A., et al. Evaluation of blood biochemistry and cardiopulmonary status of hospitalized COVID-19 patients in 3 months post discharged follow up survey. Clin Med Insights Circ Respir Pulm Med. 2022;16:11795484221119332. https://doi.org/10.1177/11795484221119332.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Notarte K.I., de Oliveira M.H.S., Peligro P.J., Velasco J.V., Macaranas I., Ver A.T., Pangilinan F.C., Pastrana A., Goldrich N., Kavteladze D., Gellaco M.M.L., Liu J., Lippi G., Henry B.M., Fernández-de-Las-Peñas C. Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: A Systematic Review and Meta-Analysis // J Clin Med. 2022. № 11(24). Р.7314. https://doi.org/10.3390/jcm11247314.</mixed-citation><mixed-citation xml:lang="en">Notarte KI, de Oliveira MHS., Peligro PJ, Velasco JV, Macaranas I, Ver AT., et al. Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: A Systematic Review and Meta-Analysis. J Clin Med. 2022;11(24):7314. https://doi.org/10.3390/jcm11247314.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Peghin M., Palese A., Venturini M., De Martino M., Gerussi V., Graziano E., Bontempo G., Marrella F., Tommasini A., Fabris M., Curcio F., Isola M., Tascini C. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients // Clin Microbiol Infect. 2021. № 27(10). Р.1507–1513. https://doi.org/10.1016/j.cmi.2021.05.033.</mixed-citation><mixed-citation xml:lang="en">Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E., et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27(10):1507-1513. https://doi.org/10.1016/j.cmi.2021.05.033.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Phan L.T., Nguyen T.V., Luong Q.C., Nguyen T.V., Nguyen H.T., Le H.Q., Nguyen T.T., Cao T.M., Pham Q.D. Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam // N Engl J Med. 2020. Vol. 382. № 9. P. 872-874. https://doi.org/10.1056/NEJMc2001272.</mixed-citation><mixed-citation xml:lang="en">Phan LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HT, Le HQ., et al. Importation and Humanto-Human Transmission of a Novel Coronavirus in Vietnam. N Engl J Med. 2020;382;9:872-874. https://doi.org/10.1056/NEJMc2001272.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Rothe C., Schunk M., Sothmann P., Bretzel G., Froeschl G., Wallrauch C., Zimmer T., Thiel V., Janke C., Guggemos W., Seilmaier M., Drosten C., Vollmar P., Zwirglmaier K., Zange S., Wölfel R., Hoelscher M. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany // N Engl J Med. 2020. Vol. 382. № 10. P. 970-971. https://doi.org/10.1056/NEJMc2001468.</mixed-citation><mixed-citation xml:lang="en">Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C., et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020;382;10:970–971. https://doi.org/10.1056/NEJMc2001468.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Rubin R. As their numbers grow, COVID-19 «Long haulers» stump experts // JAMA. 2020. Vol. 324. № 14. P.1381–1383. https://doi.org/10.1001/jama.2020.17709.</mixed-citation><mixed-citation xml:lang="en">Rubin R. As their numbers grow, COVID-19 «Long haulers» stump experts. JAMA. 2020;324;14:1381-1383. https://doi.org/10.1001/jama.2020.17709.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Shang L., Wang L., Zhou F., Li J., Liu Y., Yang S. Long-term effects of obesity on COVID-19 patients discharged from hospital // Immun Inflamm Dis. 2021. № 9(4). Р.1678-1685. https://doi.org/10.1002/iid3.522.</mixed-citation><mixed-citation xml:lang="en">Shang L, Wang L, Zhou F, Li J, Liu Y, Yang S. Long-term effects of obesity on COVID-19 patients discharged from hospital. Immun Inflamm Dis. 2021;9(4);1678-1685. https://doi.org/10.1002/iid3.522.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Siegelman J.N. Reflections of a COVID-19 long hauler // JAMA. 2020. Vol. 324. № 20. P. 2031-2032. https://doi.org/10.1001/jama.2020.22130.</mixed-citation><mixed-citation xml:lang="en">Siegelman JN. Reflections of a COVID-19 long hauler. JAMA. 2020;324;20:2031-2032. https://doi.org/10.1001/jama.2020.22130.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Stavem K., Ghanima W., Olsen M.K., Gilboe H.M., Einvik G. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study // Thorax. 2021. № 76(4). Р.405–407. https://doi.org/10.1136/thoraxjnl-2020-216377.</mixed-citation><mixed-citation xml:lang="en">Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021;76(4):405-407. https://doi.org/10.1136/thoraxjnl-2020-216377.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T., Chandan J.S., Brown K., Simms-Williams N., Shah A.D., Singh M., Kidy F., Okoth K., Hotham R., Bashir N., Cockburn N., Lee S.I., Turner G.M., Gkoutos G.V., Aiyegbusi O.L., McMullan C., Denniston A.K., Sapey E., Lord J.M., Wraith D.C., Leggett E., Iles C., Marshall T., Price M.J., Marwaha S., Davies E.H., Jackson L.J., Matthews K.L., Camaradou J., Calvert M., Haroon S. Symptoms and risk factors for long COVID in non-hospitalized adults // Nat Med. 2022. № 28(8). Р.1706-1714. https://doi.org/10.1038/s41591-022-01909-w.</mixed-citation><mixed-citation xml:lang="en">Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM., et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706-14. https://doi.org/10.1038/s41591-022-01909-w.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Talic S., Shah S., Wild H., Gasevic D., Maharaj A., Ademi Z., Li X., Xu W., Mesa-Eguiagaray I., Rostron J., Theodoratou E., Zhang X., Motee A., Liew D., Ilic D. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and metaanalysis // BMJ. 2021. Vol. 375. P. e068302. https://doi.org/10.1136/bmj-2021-068302.</mixed-citation><mixed-citation xml:lang="en">Talic S, Shah S, Wild H, Gasevic D, Maharaj A, Ademi Z., et al. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis. BMJ. 2021;375:e068302. https://doi.org/10.1136/bmj-2021-068302.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia // J Thromb Haemost. 2020. Vol. 18. № 4. P. 844-847. https:// doi.org/10.1111/jth.14768.</mixed-citation><mixed-citation xml:lang="en">Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18;4:844-847. https://doi.org/10.1111/jth.14768.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. Coronavirus disease (COVID-19) outbreak (https://www.who.int).</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Coronavirus disease (COVID-19) outbreak. Available from: https://www.who.int.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Wulf Hanson S., Abbafati C., Aerts J.G., Al-Aly Z., Ashbaugh C., Ballouz T., Blyuss O., Bobkova P., Bonsel G., Borzakova S., Buonsenso D., Butnaru D., Carter A., Chu H., De Rose C., Diab M.M., Ekbom E., El Tantawi M., Fomin V., Frithiof R., Gamirova A., Glybochko P.V., Haagsma J.A., Haghjooy Javanmard S., Hamilton E.B., Harris G., Heijenbrok-Kal M.H., Helbok R., Hellemons M.E., Hillus D., Huijts S.M., Hultström M., Jassat W., Kurth F., Larsson I.M., Lipcsey M., Liu C., Loflin C.D., Malinovschi A., Mao W., Mazankova L., McCulloch D., Menges D., Mohammadifard N., Munblit D., Nekliudov N.A., Ogbuoji O., Osmanov I.M., Peñalvo J.L., Petersen M.S., Puhan M.A., Rahman M., Rass V., Reinig N., Ribbers G.M., Ricchiuto A., Rubertsson S., Samitova E., Sarrafzadegan N., Shikhaleva A., Simpson K.E., Sinatti D., Soriano J.B., Spiridonova E., Steinbeis F., Svistunov A.A., Valentini P., van de Water B.J., van den Berg-Emons R., Wallin E., Witzenrath M., Wu Y., Xu H., Zoller T., Adolph C., Albright J., Amlag J.O., Aravkin A.Y., Bang-Jensen B.L., Bisignano C., Castellano R., Castro E., Chakrabarti S., Collins J.K., Dai X., Daoud F., Dapper C., Deen A., Duncan B.B., Erickson M., Ewald S.B., Ferrari A.J., Flaxman A.D., Fullman N., Gamkrelidze A., Giles J.R., Guo G., Hay S.I., He J., Helak M., Hulland E.N., Kereselidze M., Krohn K.J., Lazzar-Atwood A., Lindstrom A., Lozano R., Malta D.C., Månsson J., Mantilla Herrera A.M., Mokdad A.H., Monasta L., Nomura S., Pasovic M., Pigott D.M., Reiner R.C. Jr, Reinke G., Ribeiro A.L.P., Santomauro D.F., Sholokhov A., Spurlock E.E., Walcott R., Walker A., Wiysonge C.S., Zheng P., Bettger J.P., Murray C.J.L., Vos T. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021 // JAMA. 2022. № 328(16). Р.1604-15. https:// doi.org/10.1001/jama.2022.18931.</mixed-citation><mixed-citation xml:lang="en">Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T., et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604-1615. https://doi.org/10.1001/jama.2022.18931.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Xu E., Xie Y., Al-Aly Z. Long-term neurologic outcomes of COVID-19 // Nat Med. 2022. № 28(11). Р.2406-2415. https://doi.org/10.1038/s41591-022-02001-z.</mixed-citation><mixed-citation xml:lang="en">Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med. 2022;28(11):2406-2415. Https://doi.org/10.1038/s41591-022-02001-z.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Yang T., Yan M.Z., Li X., Lau E.H.Y. Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis // Infection. 2022. № 50(5). Р.1067–1109. https://doi.org/10.1007/s15010-022-01862-3.</mixed-citation><mixed-citation xml:lang="en">Yang T, Yan MZ, LiX, Lau EHY. Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis. Infection. 2022;50(5):1067-1109. https://doi.org/10.1007/s15010-022-01862-3.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Yazji B., Voduc N., Mulpuru S., Cowan J. Pulmonary sequelae of SARS-CoV-2 infection and factors associated with persistent abnormal lung function at six months after infection: Prospective cohort study // PLoS One. 2022. № 17(11). Р.e0277624. https://doi.org/10.1371/journal.pone.0277624.</mixed-citation><mixed-citation xml:lang="en">Yazji B, Voduc N, Mulpuru S, Cowan J. Pulmonary sequelae of SARS-CoV-2 infection and factors associated with persistent abnormal lung function at six months after infection: Prospective cohort study. PLoS One. 2022;17(11):e0277624. https://doi.org/10.1371/journal.pone.0277624.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
